Receptos utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.
QuatRx Pharmaceuticals is a pharmaceutical company focused on discovering, licensing, developing, and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas.
Pharmacyclics develops treatments for certain cancers, cardiovascular diseases, and other disorders utilizing small molecules (biometallic pharmaceuticals) that bind metals to capture and focus forms of energy used in a variety of medical applications.
Millennium Pharmaceuticals develops breakthrough treatments for cancer and inflammatory diseases.
Cymabay Therapeutics discovers and develops small molecule drugs for the treatment of diabetes and related metabolic disorders.
Memory Pharmaceuticals develops small molecule therapeutics for memory-related neurological diseases and for psychiatric indications.
Liposome Company manufactures commercialized drug delivery systems based on liposomes.
Ligand discovers and develops therapeutics based on intracelluar receptors for the treatment of human disease.
Ironwood Pharmaceuticals (formerly Microbia) is dedicated to creating, developing, and commercializing innovative human medicines, and has clinical stage programs in GI disorders and dyslipidemia.
Infinity Pharmaceuticals is a drug discovery company that is developing and integrating unique approaches and capabilities in synthetic chemistry, chemical genetics, informatics, and biological screening.